CMR in inflammatory vasculitis

Journal of Cardiovascular Magnetic Resonance

Volumn 14, Issue 1, 2012, Pages

  Raman, Subha V ^a   Aneja, Ashish ^a   Jarjour, Wael N ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Angiography; Imaging; Inflammation; Magnetic resonance; Vasculitis

Indexed keywords

IMMUNOGLOBULIN; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ABDOMINAL AORTA; AORTA ARCH SYNDROME; AORTA DISSECTION; AORTITIS; ARM; ARTERIAL WALL THICKNESS; BEHCET DISEASE; BLOOD VESSEL BIOPSY; CARDIOVASCULAR MAGNETIC RESONANCE; CAROTID ARTERIOGRAPHY; CHURG STRAUSS SYNDROME; CONTRAST ENHANCEMENT; CORONARY ARTERY; CORONARY ARTERY ANEURYSM; DISEASE SEVERITY; ELECTROCARDIOGRAPHY; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; GIANT CELL; GIANT CELL ARTERITIS; HEART INFARCTION; HEART MUSCLE FIBROSIS; HISTOPATHOLOGY; HUMAN; IDIOPATHIC AORTITIS; IDIOPATHIC DISEASE; ISCHEMIC HEART DISEASE; JAW PAIN; LEG; MAGNETIC RESONANCE ANGIOGRAPHY; MESENTERIC ARTERY; MOLECULAR BIOLOGY; MUCOCUTANEOUS LYMPH NODE SYNDROME; MULTIDETECTOR COMPUTED TOMOGRAPHY; MYOCARDIAL DISEASE; PERICARDITIS; POLYARTERITIS NODOSA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PULMONARY ARTERY; RENAL ARTERY; REVIEW; SMALL VESSEL VASCULITIS; THORACIC AORTA; THORAX PAIN; THROMBOSIS; VASCULITIS;

ADULT; AGED; ANIMALS; BLOOD VESSELS; CHILD; CONTRAST MEDIA; FEMALE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MICROVESSELS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; VASCULITIS;

EID: 84870184780     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-14-82     Document Type: Review

References (75)

1. Systemic vasculitis: epidemiology, classification and environmental factors. Scott DG, Watts RA, Ann Rheum Dis 2000 59 161 163 10.1136/ard.59.3.161 10700420
2. Epidemiology of the vasculitides. Gonzalez-Gay MA, Garcia-Porrua C, Rheum Dis Clin North Am 2001 27 729 749 10.1016/S0889-857X(05)70232-5 11723761
3. The diagnosis of vasculitis. Jayne D, Best Pract Res Clin Rheumatol 2009 23 445 453 10.1016/j.berh.2009.03.001 19508950
4. Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update. Pipitone N, Versari A, Salvarani C, Rheumatology (Oxford) 2008 47 403 408
5. How to diagnose and treat secondary forms of vasculitis. Luqmani RA, Pathare S, Kwok-Fai TL, Best Pract Res Clin Rheumatol 2005 19 321 336 10.1016/j.berh.2004.11.002 15857799
6. Is there a place for cardiovascular magnetic resonance imaging in the evaluation of cardiovascular involvement in rheumatic diseases? Mavrogeni S, Vassilopoulos D, Semin Arthritis Rheum 2011 41 488 496 10.1016/j.semarthrit. 2011.04.004 21641017
7. Imaging findings in primary central nervous system vasculitis. Zuccoli G, Pipitone N, Haldipur A, Brown RD Jr, Hunder G, Salvarani C, Clin Exp Rheumatol 2011 29 104 S109 22243557
8. Diagnosis and treatment of cerebral vasculitis. Berlit P, Ther Adv Neurol Disord 2010 3 29 42 10.1177/1756285609347123 21180634
9. Magnetic resonance angiography: current status and future directions. Hartung MP, Grist TM, Francois CJ, J Cardiovasc Magn Reson 2011 13 19 10.1186/1532-429X-13-19 21388544
10. Image quality and diagnostic accuracy of unenhanced SSFP MR angiography compared with conventional contrast-enhanced MR angiography for the assessment of thoracic aortic diseases. Krishnam MS, Tomasian A, Malik S, Desphande V, Laub G, Ruehm SG, Eur Radiol 2009 20 1311 1320 20013276
11. Post-interventional three-dimensional dark blood MRI in the adult with congenital heart disease. 3rd Winner MW, Raman SV, Chung YC, Simonetti OP, Mihai G, Cook SC, Int J Cardiol 2012 158 2 276 71
12. Evaluation of peripheral arterial disease with nonenhanced quiescent-interval single-shot MR angiography. Hodnett PA, Koktzoglou I, Davarpanah AH, Scanlon TG, Collins JD, Sheehan JJ, Dunkle EE, Gupta N, Carr JC, Edelman RR, Radiology 2011 260 282 293 10.1148/radiol.11101336 21502384
13. Vasculitis. Langford CA, J Allergy Clin Immunol 2009 125 216 225 19932919
14. Giant cell arteritis: A review of classification, pathophysiology, geoepidemiology and treatment. Borchers AT, Gershwin ME, Autoimmun Rev 2012 11 544 554 10.1016/j.autrev.2012.01.003 22285588
15. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, et al. Arthritis Rheum 1990 33 1122 1128 2202311
16. Diagnosis and management of giant cell arteritis: a review. Kale N, Eggenberger E, Curr Opin Ophthalmol 2010 21 417 422 10.1097/ICU.0b013e32833eae8b 20811283
17. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. Evans JM, O'Fallon WM, Hunder GG, A population-based study. Ann Intern Med 1995 122 502 507
18. Mortality of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Nuenninghoff DM, Hunder GG, Christianson TJ, McClelland RL, Matteson EL, Arthritis Rheum 2003 48 3532 3537 10.1002/art.11480 14674005
19. Aortic involvement in giant cell arteritis: current data. Bossert M, Prati C, Balblanc JC, Lohse A, Wendling D, Joint Bone Spine 2010 78 246 251 21030278
20. Aortic involvement in giant cell arteritis. Martinez-Valle F, Solans-Laque R, Bosch-Gil J, Vilardell-Tarres M, Autoimmun Rev 2010 9 521 524 10.1016/j.autrev.2010.02.014 20149900
21. Magnetic resonance angiography in extracranial giant cell arteritis. Koenigkam-Santos M, Sharma P, Kalb B, Oshinski JN, Weyand CM, Goronzy JJ, Martin DR, J Clin Rheumatol 2011 17 306 310 21869711
22. Long-term follow-up of upper and lower extremity vasculitis related to giant cell arteritis: a series of 36 patients. Assie C, Janvresse A, Plissonnier D, Levesque H, Marie I, Medicine (Baltimore) 2011 90 40 51 10.1097/MD. 0b013e318206af16
23. Meta-analysis: test performance of ultrasonography for giant-cell arteritis. Karassa FB, Matsagas MI, Schmidt WA, Ioannidis JP, Ann Intern Med 2005 142 359 369 15738455
24. EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis. Basu N, Watts R, Bajema I, Baslund B, Bley T, Boers M, Brogan P, Calabrese L, Cid MC, Cohen-Tervaert JW, et al. Ann Rheum Dis 2010 69 10 1744 1750 10.1136/ard.2009.119032 20448283
25. High-resolution MRI in giant cell arteritis: imaging of the wall of the superficial temporal artery. Bley TA, Wieben O, Uhl M, Thiel J, Schmidt D, Langer M, AJR Am J Roentgenol 2005 184 283 287 15615989
26. Assessment of the cranial involvement pattern of giant cell arteritis with 3T magnetic resonance imaging. Bley TA, Weiben O, Uhl M, Vaith P, Schmidt D, Warnatz K, Langer M, Arthritis Rheum 2005 52 2470 2477 10.1002/art.21226 16052572
27. The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Walter MA, Melzer RA, Schindler C, Muller-Brand J, Tyndall A, Nitzsche EU, Eur J Nucl Med Mol Imaging 2005 32 674 681 10.1007/s00259-004-1757-9 15747154
28. Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI. Meller J, Strutz F, Siefker U, Scheel A, Sahlmann CO, Lehmann K, Conrad M, Vosshenrich R, Eur J Nucl Med Mol Imaging 2003 30 730 736 10.1007/s00259-003- 1144-y 12677302
29. Quantification of supra-aortic arterial wall inflammation in patients with arteritis using high resolution dynamic contrast-enhanced magnetic resonance imaging: initial results in correlation to [18F]-FDG PET/CT. Cyran CC, Sourbron S, Bochmann K, Habs M, Pfefferkorn T, Rominger A, Raya JG, Reiser MF, Dichgans M, Nikolaou K, et al. Invest Radiol 2011 46 9 594 599 10.1097/RLI.0b013e31821c44ed 21577125
30. Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Blockmans D, de Ceuninck L, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H, Arthritis Rheum 2006 55 131 137 10.1002/art.21699 16463425
31. MRI and FDG-PET in the assessment of inflammatory aortic arch syndrome in complicated courses of giant cell arteritis. Both M, Ahmadi-Simab K, Reuter M, Dourvos O, Fritzer E, Ullrich S, Gross WL, Heller M, Bahre M, Ann Rheum Dis 2008 67 1030 1033 18223265
32. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, Kawasaki T, Lindsley C, Petty RE, Prieur AM, et al. Ann Rheum Dis 2006 65 936 941 16322081
33. Cluster analysis of arterial involvement in Takayasu arteritis reveals symmetric extension of the lesions in paired arterial beds. Arnaud L, Haroche J, Toledano D, Cacoub P, Mathian A, Costedoat-Chalumeau N, Le Thi Huong-Boutin D, Cluzel P, Gorochov G, Amoura Z, Arthritis Rheum 2011 63 1136 1140 10.1002/art.30240 21452331
34. Takayasu arteritis: diagnosis with breath-hold contrast-enhanced three-dimensional MR angiography. Yamada I, Nakagawa T, Himeno Y, Kobayashi Y, Numano F, Shibuya H, J Magn Reson Imaging 2000 11 481 487 10.1002/(SICI)1522- 2586(200005)11:5<481::AID-JMRI3>3.0.CO;2-4 10813857
35. Diagnostic value of 3D contrast-enhanced magnetic resonance angiography in Takayasu's arteritis - a comparative study with digital subtraction angiography. Garg SK, Mohan S, Kumar S, Eur Radiol 2011 21 8 1658 1666 10.1007/s00330-011-2090-x 21344303
36. Non-invasive imaging in the diagnosis and management of Takayasu's arteritis. Andrews J, Al-Nahhas A, Pennell DJ, Hossain MS, Davies KA, Haskard DO, Mason JC, Ann Rheum Dis 2004 63 995 1000 10.1136/ard.2003.015701 15249328
37. Detecting disease extent and activity of Takayasu arteritis using whole-body magnetic resonance angiography and vessel wall imaging as a 1-stop solution. Li D, Lin J, Yan F, J Comput Assist Tomogr 2011 35 468 474 10.1097/RCT.0b013e318222d698 21765303
38. Delayed contrast-enhanced MRI of the aortic wall in Takayasu's arteritis: initial experience. Desai MY, Stone JH, Foo TK, Hellmann DB, Lima JA, Bluemke DA, AJR Am J Roentgenol 2005 184 1427 1431 15855090
39. Takayasu's arteritis: assessment of disease activity with contrast-enhanced MR imaging. Choe YH, Han BK, Koh EM, Kim DK, Do YS, Lee WR, AJR Am J Roentgenol 2000 175 505 511 10915704
40. Evaluation of Takayasu arteritis activity by delayed contrast-enhanced magnetic resonance imaging. Jiang L, Li D, Yan F, Dai X, Li Y, Ma L, Int J Cardiol 2012 155 2 262 267 10.1016/j.ijcard.2010.10.002 21059475
41. Takayasu arteritis: utility and limitations of magnetic resonance imaging in diagnosis and treatment. Tso E, Flamm SD, White RD, Schvartzman PR, Mascha E, Hoffman GS, Arthritis Rheum 2002 46 1634 1642 10.1002/art.10251 12115196
42. Takayasu arteritis: lessons from the American National Institutes of Health experience. Hoffman GS, Int J Cardiol 1996 54 Suppl 99 102 9119532
43. Noninfectious ascending aortitis: a case series of 64 patients. Liang KP, Chowdhary VR, Michet CJ, Miller DV, Sundt TM, Connolly HM, Crowson CS, Matteson EL, Warrington KJ, J Rheumatol 2009 36 2290 2297 10.3899/jrheum.090081 19648309
44. A clinical overview of IgG4-related systemic disease. Khosroshahi A, Stone JH, Curr Opin Rheumatol 2011 23 57 66 10.1097/BOR.0b013e3283418057 21124086
45. The pathology of large-vessel vasculitides. Miller DV, Maleszewski JJ, Clin Exp Rheumatol 2011 29 92 98 22243555
46. Aortitis, periaortitis, and retroperitoneal fibrosis, as manifestations of IgG4-related systemic disease. Stone JR, Curr Opin Rheumatol 2010 23 88 94
47. Predictors for pathologically confirmed aortitis after resection of the ascending aorta: a 12-year Danish nationwide population-based cross-sectional study. Schmidt J, Sunesen K, Kornum JB, Duhaut P, Thomsen RW, Arthritis Res Ther 2011 13 87 10.1186/ar3360 21676237
48. Study of 52 patients with idiopathic aortitis from a cohort of 1,204 surgical cases. Rojo-Leyva F, Ratliff NB, 3rd Cosgrove DM, Hoffman GS, Arthritis Rheum 2000 43 901 907 10.1002/1529-0131(200004)43:4<901::AID-ANR23>3.0. CO;2-U 10765937
49. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, et al. American Heart Association. Circulation 2004 110 2747 2771
50. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, Kazue T, Eto G, Yamakawa R, Circulation 1996 94 1379 1385 10.1161/01.CIR.94.6. 1379 8822996
51. When children with Kawasaki disease grow up: myocardial and vascular complications in adulthood. Gordon JB, Kahn AM, Burns JC, J Am Coll Cardiol 2009 54 1911 1920 10.1016/j.jacc.2009.04.102 19909870
52. Mortality among persons with a history of kawasaki disease in Japan: mortality among males with cardiac sequelae is significantly higher than that of the general population. Nakamura Y, Aso E, Yashiro M, Uehara R, Watanabe M, Oki I, Yanagawa H, Circ J 2008 72 134 138 10.1253/circj.72.134 18159114
53. Predictors of coronary artery visualization in Kawasaki disease. Margossian R, Lu M, Minich LL, Bradley TJ, Cohen MS, Li JS, Printz BF, Shirali GS, Sleeper LA, Newburger JW, Colan SD, J Am Soc Echocardiogr 2011 24 53 59 10.1016/j.echo.2010.10.015 21172596
54. Coronary magnetic resonance angiography and vessel wall imaging in children with Kawasaki disease. Greil GF, Seeger A, Miller S, Claussen CD, Hofbeck M, Botnar RM, Sieverding L, Pediatr Radiol 2007 37 666 673 10.1007/s00247-007-0498-x 17541574
55. Cardiac magnetic resonance imaging for noninvasive assessment of cardiovascular disease during the follow-up of patients with Kawasaki disease. Tacke CE, Kuipers IM, Groenink M, Spijkerboer AM, Kuijpers TW, Circ Cardiovasc Imaging 2011 4 712 720 10.1161/CIRCIMAGING.111.965996 21921132
56. Coronary magnetic resonance angiography in adolescents and young adults with kawasaki disease. Greil GF, Stuber M, Botnar RM, Kissinger KV, Geva T, Newburger JW, Manning WJ, Powell AJ, Circulation 2002 105 908 911 10.1161/hc0802.105563 11864916
57. Magnetic resonance angiography is equivalent to X-ray coronary angiography for the evaluation of coronary arteries in Kawasaki disease. Mavrogeni S, Papadopoulos G, Douskou M, Kaklis S, Seimenis I, Baras P, Nikolaidou P, Bakoula C, Karanasios E, Manginas A, Cokkinos DV, J Am Coll Cardiol 2004 43 649 652 10.1016/j.jacc.2003.08.052 14975477
58. Magnetic resonance coronary angiography to evaluate coronary arterial lesions in patients with Kawasaki disease. Suzuki A, Takemura A, Inaba R, Sonobe T, Tsuchiya K, Korenaga T, Cardiol Young 2006 16 563 571 10.1017/ S1047951106001168 17116270
59. Visualization of coronary arteries in patients after childhood Kawasaki syndrome: value of multidetector CT and MR imaging in comparison to conventional coronary catheterization. Arnold R, Ley S, Ley-Zaporozhan J, Eichhorn J, Schenk JP, Ulmer H, Kauczor HU, Pediatr Radiol 2007 37 998 1006 10.1007/s00247-007- 0566-2 17768616
60. Safety and accuracy of dual-source coronary computed tomography angiography in the pediatric population. Han BK, Lindberg J, Overman D, Schwartz RS, Grant K, Lesser JR, J Cardiovasc Comput Tomogr 2012 6 252 259 10.1016/j.jcct.2012.01.004 22732198
61. CMR evaluation of cardiac involvement during the convalescence of Kawasaki disease. Mavrogeni S, Bratis K, Karanasios E, Georgakopoulos D, Kaklis S, Varlamis G, Kolovou G, Douskou M, Papadopoulos G, JACC Cardiovasc Imaging 2011 4 1140 1141 10.1016/j.jcmg.2011.04.021 21999875
62. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, et al. American Heart Association. Pediatrics 2004 114 1708 1733
63. A paradigm of diagnostic criteria for polyarteritis nodosa: analysis of a series of 949 patients with vasculitides. Henegar C, Pagnoux C, Puechal X, Zucker JD, Bar-Hen A, Le Guern V, Saba M, Bagneres D, Meyer O, Guillevin L, Arthritis Rheum 2008 58 1528 1538 10.1002/art.23470 18438816
64. Detection of coronary artery lesions and myocardial necrosis by magnetic resonance in systemic necrotizing vasculitides. Mavrogeni S, Manoussakis MN, Karagiorga TC, Douskou M, Panagiotakos D, Bournia V, Cokkinos DV, Moutsopoulos HM, Arthritis Rheum 2009 61 1121 1129 10.1002/art.24695 19644909
65. Cardiac magnetic resonance imaging in polyarteritis nodosa. Kobayashi H, Yokoe I, Hattan N, Ohta H, Nakajima Y, Kobayashi Y, J Rheumatol 2010 37 2427 2429 10.3899/jrheum.100450 21041263
66. Risk of subsequent coronary heart disease in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden. Zöller B, Li X, Sundquist J, Sundquist K, PLoS One 2012 7 33442 10.1371/journal.pone. 0033442 22438933
67. Vascular involvement in Behcet's disease: a retrospective analysis of 2319 cases. Sarica-Kucukoglu R, Akdag-Kose A, Kayabal IM, Yazganoglu KD, Disci R, Erzengin D, Azizlerli G, Int J Dermatol 2006 45 919 921 10.1111/j.1365-4632. 2006.02832.x 16911374
68. Major vessel involvement in Behcet's disease: an update. Calamia KT, Schirmer M, Melikoglu M, Curr Opin Rheumatol 2011 23 24 31 10.1097/BOR. 0b013e3283410088 21124084
69. Spectrum of cardiac lesions in Behcet disease: a series of 52 patients and review of the literature. Geri G, Wechsler B, Thi Huong Du L, Isnard R, Piette JC, Amoura Z, Resche-Rigon M, Cacoub P, Saadoun D, Medicine (Baltimore) 2012 91 25 34 10.1097/MD.0b013e3182428f49
70. Multimodality assessment of cardiac involvement in Churg-Strauss syndrome patients in clinical remission. Szczeklik W, Miszalski-Jamka T, Mastalerz L, Sokolowska B, Dropinski J, Banys R, Hor KN, Mazur W, Musial J, Circ J 2011 75 649 655 10.1253/circj.CJ-10-0772 21139253
71. Heart involvement in Churg-Strauss syndrome: retrospective study in French Burgundy population in past 10 years. Vinit J, Bielefeld P, Muller G, Pfitzenmeyer P, Bonniaud P, Lorcerie B, Besancenot JF, Eur J Intern Med 2010 21 341 346 10.1016/j.ejim.2010.05.004 20603049
72. Cardiovascular magnetic resonance imaging detects cardiac involvement in Churg-Strauss syndrome. Wassmuth R, Gobel U, Natusch A, Schneider W, Kettritz R, Dietz R, Luft FC, Schulz-Menger J, J Card Fail 2008 14 856 860 10.1016/j.cardfail.2008.07.227 19041050
73. Images in cardiovascular medicine, Infiltrative eosinophilic myocarditis diagnosed and localized by cardiac magnetic resonance imaging. Chun W, Grist TM, Kamp TJ, Warner TF, Christian TF, Circulation 2004 110 19 10.1161/01.CIR. 0000135586.94417.3C 15262855
74. Subendocardial and papillary muscle involvement in a patient with Churg-Strauss syndrome, detected by contrast enhanced cardiovascular magnetic resonance. Petersen SE, Kardos A, Neubauer S, Heart 2005 91 9 10.1136/hrt.2004.050070 15604316
75. Vasculitis: molecular imaging by targeting the inflammatory enzyme myeloperoxidase. Su HS, Nahrendorf M, Panizzi PR, Breckwoldt MO, Rodriguez E, Iwamoto Y, Aikawa E, Weissleder R, Chen JW, Radiology 2011 262 1 181 90 22084204